This selective action depended on the synergy between high Kv1.3 expression and altered basal redox state in cancer cells, since pretreatment of mice with a molecule able to exert ROS scavenging was able to prevent the tumor-reducing effect of PAP-1 derivatives. The gene discussed is KCNA3; the disease is cancer.